Holdings

Eaton Vance Worldwide Health Sciences Fund

As of May 31, 2026, Eaton Vance Worldwide Health Sciences Fund reported 41 positions worth US$753M. Largest: Eli Lilly and Company, AbbVie Inc. and Johnson & Johnson. What it bought and sold, with each filing.

Holdings

Positions
41
Value as reported
US$753M
Holdings as of
May 31, 2026
Last filed
Jul 27, 2026
CompanySharesValue as reported% of portfolioChangeAs of
Eli Lilly and Company
NYSE:LLY
85,543US$94.5M12.5%−6,863May 31, 2026
AbbVie Inc.
NYSE:ABBV
225KUS$48.9M6.5%−21,559May 31, 2026
Johnson & Johnson
NYSE:JNJ
217KUS$48.9M6.4%No changeMay 31, 2026
AstraZeneca PLC
LSE:AZN
255KUS$47.3M6.2%−11,968May 31, 2026
UnitedHealth Group Incorporated
NYSE:UNH
109KUS$41.6M5.5%No changeMay 31, 2026
Roche Holding Ltd
SIX:RO
98,026US$41.2M5.4%−27,800May 31, 2026
Merck & Company, Inc.
NYSE:MRK
324KUS$38.5M5.1%+16,988May 31, 2026
Bristol-Myers Squibb Company
NYSE:BMY
564KUS$32.2M4.3%No changeMay 31, 2026
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
57,284US$25.6M3.4%−3,396May 31, 2026
Gilead Sciences, Inc.
NASDAQ:GILD
188KUS$25.3M3.3%No changeMay 31, 2026
Sanofi SA
EURONEXT:SAN
255KUS$22.3M2.9%No changeMay 31, 2026
Thermo Fisher Scientific Inc
NYSE:TMO
42,998US$21.2M2.8%−4,192May 31, 2026
Intuitive Surgical, Inc.
NASDAQ:ISRG
48,480US$20.6M2.7%No changeMay 31, 2026
Stryker Corporation
NYSE:SYK
54,948US$16.8M2.2%No changeMay 31, 2026
Boston Scientific Corporation
NYSE:BSX
341KUS$16.5M2.2%+47,110May 31, 2026
Medtronic plc.
NYSE:MDT
185KUS$13.7M1.8%No changeMay 31, 2026
Lonza Group AG
SIX:LONN
21,010US$13.4M1.8%−974May 31, 2026
Novo Nordisk A/S Class B
OMXCOP:NOVO_B
284KUS$13M1.7%No changeMay 31, 2026
Abbott Laboratories
NYSE:ABT
146KUS$12.5M1.7%−90,441May 31, 2026
Novartis AG
SIX:NOVN
83,123US$12.5M1.6%+13,094May 31, 2026
argenx SE
EURONEXT:ARGX
14,601US$12.2M1.6%−2,942May 31, 2026
Royalty Pharma plc
NASDAQ:RPRX
215KUS$12M1.6%No changeMay 31, 2026
Neurocrine Biosciences, Inc.
NASDAQ:NBIX
67,430US$10.7M1.4%+15,776May 31, 2026
Mettler-Toledo International, Inc.
NYSE:MTD
8,731US$10.3M1.4%No changeMay 31, 2026
Straumann Holding AG
SIX:STMN
83,976US$10.1M1.3%No changeMay 31, 2026
Quest Diagnostics Incorporated
NYSE:DGX
50,412US$9.83M1.3%NewMay 31, 2026
Genmab A/S
OMXCOP:GMAB
34,565US$9.06M1.2%+17,875May 31, 2026
Edwards Lifesciences Corporation
NYSE:EW
103KUS$8.87M1.2%−43,738May 31, 2026
Zoetis Inc.
NYSE:ZTS
109KUS$8.5M1.1%−91,247May 31, 2026
The Cooper Companies, Inc.
NASDAQ:COO
128KUS$7.85M1.0%No changeMay 31, 2026
CSL Limited
ASX:CSL
99,071US$6.88M0.91%−35,091May 31, 2026
Heartflow, Inc.
NASDAQ:HTFL
219KUS$6.78M0.90%No changeMay 31, 2026
Danaher Corporation
NYSE:DHR
37,052US$6.77M0.89%No changeMay 31, 2026
Recordati S.p.A.
MIL:REC
91,672US$5.51M0.73%No changeMay 31, 2026
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
100KUS$5.48M0.72%+48,772May 31, 2026
Generate Biomedicines, Inc.
NASDAQ:GENB
313KUS$4.1M0.54%NewMay 31, 2026
Apogee Therapeutics, Inc.
NASDAQ:APGE
33,655US$2.76M0.36%No changeMay 31, 2026
NewAmsterdam Pharma Company N.V.
NASDAQ:NAMS
81,652US$2.75M0.36%No changeMay 31, 2026
Caris Life Sciences, Inc.
NASDAQ:CAI
136KUS$2.27M0.30%No changeMay 31, 2026
EssilorLuxottica SA
EURONEXT:EL
10,648US$2.15M0.28%No changeMay 31, 2026
MBX Biosciences, Inc.
NASDAQ:MBX
59,688US$1.88M0.25%NewMay 31, 2026